• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 PER-Q-CATH PLUS PICC 3F WITH STIFFENING STYLET WIRE (SINGLE-LUMEN); CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 PER-Q-CATH PLUS PICC 3F WITH STIFFENING STYLET WIRE (SINGLE-LUMEN); CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS Back to Search Results
Model Number N/A
Medical Device Problem Code Break (1069)
Health Effect - Clinical Codes Foreign Body In Patient (2687); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/28/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of reeq3692 showed five other similar product complaint(s) from this lot number.
 
Event or Problem Description
It was reported that when the catheter was removed, at which time the device was ruptured, requiring surgical intervention for total removal.
 
Event or Problem Description
It was reported that when the catheter was removed, at which time the device was ruptured, requiring surgical intervention for total removal.Additional information received: customer sent to us the additional information.Please see bellow.What is the date of occurrence of the event? (b)(6) 2021.How long has the patient used the catheter? (b)(6) 2021.Was there a migration of the catheter fragment in the patient? yes.Was there any harm to the patient beyond the need for surgical intervention? (detail) after the surgical intervention, he remained intubated and was referred to the pediatric icu.Was there a need for any additional medical intervention? (detail) in the pediatric icu, the patient was extubated within the first few hours and remained under observation.Released to the inpatient post on the same day.Was there an extension of the patient's hospital stay? (detail) yes, 48 hours.Was the product being used in the management of covid-19? no.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The device has not been returned to the manufacturer for evaluation.H3 other text : device not returned for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PER-Q-CATH PLUS PICC 3F WITH STIFFENING STYLET WIRE (SINGLE-LUMEN)
Common Device Name
CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
MDR Report Key12211022
Report Number3006260740-2021-02893
Device Sequence Number17388677
Product Code LJS
UDI-Device Identifier00801741074844
UDI-Public(01)00801741074844
Combination Product (Y/N)N
Initial Reporter CountryBR
PMA/510(K) Number
K954104
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Reporter Type Manufacturer
Report Source health professional,other
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2023
Device Model NumberN/A
Device Catalogue Number4133105
Device Lot NumberREEQ3692
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 07/02/2021
Supplement Date Received by Manufacturer08/05/2021
Initial Report FDA Received Date07/22/2021
Supplement Report FDA Received Date09/02/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-